Pharmacy Can't Dodge Novo Nordisk's Diabetes Drug Suit

By Mike Curley · August 15, 2024, 7:18 PM EDT

A Tennessee federal judge on Thursday declined to throw out a suit by Novo Nordisk Inc. alleging that DCA Pharmacy is selling drugs with the same active ingredient as its Ozempic...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

Novo Nordisk Inc. v. DCA Pharmacy

Case Number

Court

Tennessee Middle

Nature of Suit

Personal Property: Other

Date Filed

July 06, 2023

Recent Articles By Mike

August 14, 2024
Florida AG Can't Nix Hospitals', School Boards' Opioid Claims
August 02, 2024
6th Circ. Upholds Federal Hospital's Win In Infant Death Suit
August 02, 2024
Four Plaintiffs Tossed From Merck Gardasil Vaccine MDL
July 26, 2024
Judge Allows Emotional Damages In Deaf Patient's Bias Suit
July 16, 2024
3rd Circ. Backs Tossing Over 1K Suits In Merck Vaccine MDL
June 28, 2024
Philips Gets OK For $25M Med Monitoring Deal In CPAP MDL
June 27, 2024
Whole Foods, Hain Want Full 5th Circ. Review Of Baby Food Suit
June 20, 2024
11th Circ. Upholds $2.5M Pelvic Mesh Verdict, Rules Suit Timely
June 18, 2024
COVID Test Maker Can't Shake All Of $30M Faulty Kit Suit
May 31, 2024
Weight Loss Drug Caused Stomach Paralysis, Suit Says